Skip to content
Aminoscope
Updated September 2026

NEUVÉ Health review

Every route and lab priced

Publishes a full price matrix by route and dose, itemizes its lab panels, and warns readers off $49 semaglutide offers.

Our verdict

NEUVÉ publishes more usable pricing than anything else in this batch. Instead of one "from" figure it gives a matrix: semaglutide at $179 injected microdose, $217 at standard dose, $138 as a daily sublingual microdose and $212 sublingual standard, with B12-free versions priced separately; tirzepatide across the same four routes at $240, $324, $160 and $282. Its lab panels are itemized from $45 to $301 rather than folded into an unexplained program fee, and it publishes a cost guide telling readers what peptide protocols should run before quoting its own — then a second guide warning that "$49 semaglutide" offers are a red flag. That is a seller arguing against its own cheapest-possible framing, which is rare and creditable. The one thing to watch is the homepage badge: "Plans from $127/mo" is the testosterone price, not a GLP-1 price.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availabilitySemaglutide $138–$217/mo and tirzepatide $160–$324 by route and dose; labs itemized from $45

At a glance

Category
GLP-1 telehealth
Access
Semaglutide $138–$217/mo and tirzepatide $160–$324 by route and dose; labs itemized from $45
Medications
Compounded semaglutide · Compounded tirzepatide
Insurance
Cash-pay, no insurance
Visit
Quiz intake / Video visit
Availability
40+ states
Updated
September 2026

Sponsored alternative

Enhance MD

Lab-guided treatment under ongoing physician oversight

Check Enhance MD availability →

What it is

A clinician-led telehealth service operated by Neuve Health, LLC, running six named programs: weight loss, peptides and longevity, hormone optimization, men's health, women's health and sexual health, with a separate lab-panel menu. Semaglutide and tirzepatide are offered as weekly injections or daily sublinguals, at microdose and standard strengths, with and without B12. It states 40+ states in one place and all 50 in others.

How it works

Clinician-reviewed with a video visit available, beginning with a three-minute assessment. Its distinguishing feature is not the care mechanics but the accounting around them: NEUVÉ prices the labs required before and during treatment as separate, named line items rather than bundling them invisibly, and its published guides explain what lab work a protocol needs and when. Neuve Health, LLC is named as the billing entity across the site. The compounding pharmacy is referenced as a licensed US compounding pharmacy but not named individually.

Pricing transparency

The fullest matrix in this batch. Semaglutide: weekly injection microdose $179/month, weekly injection standard $217, daily sublingual microdose $138, daily sublingual standard $212, weekly injection B12-free microdose $150 and standard $170. Tirzepatide: weekly injection microdose $240, standard $324, daily sublingual microdose $160, standard $282, and B12-free injection $240 and $324. Peptides: BPC-157 + TB-500 $269/month, CJC-1295 + ipamorelin $265. Hormones: testosterone cypionate from $127/month, estradiol/progesterone from $139. Labs, itemized: GLP-1 panel $45 one-time, men's TRT initial $133 and maintenance $103, women's TRT initial $70 and maintenance $128, men's comprehensive $301, women's comprehensive $293. Prices are stated to include the clinician consultation. ⚠ The homepage badge "Plans from $127/mo" is the testosterone-cypionate figure — the cheapest GLP-1 route is the $138 sublingual microdose.

Branded vs compounded

Compounded semaglutide and tirzepatide in injectable and sublingual forms at microdose and standard strengths; a peptide line of BPC-157, TB-500, CJC-1295, ipamorelin, sermorelin, NAD+, GHK-Cu and LDN; testosterone cypionate, estradiol and progesterone; and PT-141, tadalafil and oxytocin for sexual health. On the evidence: the GLP-1 outcome data is strong and belongs to the branded products rather than to compounded copies. Sublingual and microdose GLP-1 deserve particular care — neither has controlled outcome data of its own, and sublingual absorption of these peptides is not established the way subcutaneous injection is, so the cheaper sublingual routes are a convenience choice rather than an equivalent one. Sermorelin and CJC-1295/ipamorelin act on the growth-hormone axis with thin long-term outcome data; BPC-157 and TB-500 have little to no controlled human outcome evidence; injected NAD+ has none; PT-141 is approved only for HSDD in premenopausal women.

Pros and watch-outs

What we like

  • Publishes a full price matrix by molecule, route and dose rather than a single "from" figure
  • Lab panels itemized from $45 to $301 instead of folded into a program fee
  • Publishes a cost guide setting market ranges before quoting its own prices
  • Warns readers that "$49 semaglutide" offers are too good to be true — a seller arguing against cheapness
  • Operating entity named (Neuve Health, LLC); video visit available
  • Prices stated to include the clinician consultation

Watch-outs

  • The "Plans from $127/mo" badge is the testosterone price, not a GLP-1 price
  • State coverage is stated inconsistently — 40+ in one place, all 50 in others
  • The compounding pharmacy is not named individually
  • No LegitScript seal displayed
  • Sublingual routes are priced as equivalents but lack the injectables' evidence base

Best for

Readers who want every component — drug, route, dose, labs and follow-up — priced before they start, and who are comparing injection against sublingual on cost.

Who should look elsewhere

Anyone shopping purely on the lowest headline, or who wants a named pharmacy and a verifiable certification.

The evidence behind what NEUVÉ Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

How NEUVÉ Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

  • Andrew Meds

    Anyone who wants the prepay ladder and its true monthly cost published on one page

    See Andrew Meds
  • Bayan Health

    Readers who want a microdose entry point and their lab work priced in the same catalog

    See Bayan Health
  • Nex Gen Health Rx

    Buyers who want the 503A pharmacy named and the prepay total shown, not a monthly average

    See Nex Gen Health Rx
Compare all providers side by side →

More GLP-1 telehealth reviews: Strut HealthCoreAge RxOak LongevityCareBareRXSnagRxHe & She MD

JR
Julian Roth

Research & data · Reviewed and last verified September 2026

How we assessed this. This review reflects Aminoscope’s own read of NEUVÉ Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

What does "Plans from $127/mo" actually refer to?
Testosterone cypionate, not GLP-1. That figure appears on NEUVÉ's homepage as a general entry point, but tracing it through the site it is the monthly medication price on the TRT line. The cheapest GLP-1 route is the daily sublingual semaglutide microdose at $138, and the cheapest injection is $179. It is a minor mismatch by the standards of this batch — nothing is hidden, and every real figure is published — but a reader arriving from that badge for weight care will find the entry price is higher than advertised.
Is the sublingual version as good as the injection?
It is cheaper, and that is the claim we can verify. Sublingual semaglutide microdose is $138/month against $179 for the weekly injection, and sublingual tirzepatide microdose is $160 against $240. What is not established is equivalence: the trial evidence for semaglutide and tirzepatide comes from subcutaneous injection and, for oral semaglutide, from a specific formulation with an absorption enhancer. A compounded sublingual preparation is neither of those, and has no controlled outcome data of its own. Treat the sublingual route as a convenience and cost choice, not a clinically equivalent one.
Why does NEUVÉ tell readers that cheap semaglutide is a warning sign?
Its own guide on getting semaglutide online lists "prices that seem too good to be true — real compounded semaglutide costs hundreds per month, not $49" among the signals to avoid. That is a seller arguing against the framing that would most flatter a cheap competitor, and we think it is broadly right: several very low prices on this board turn out to exclude a mandatory membership or to be a twelve-month prepay. It is also, of course, an argument that happens to favor NEUVÉ's own mid-to-high pricing, so read it as informed self-interest rather than disinterested advice.
Are the lab costs included in the monthly price?
No, and NEUVÉ is unusually clear about that. Lab panels are priced as separate one-time items: $45 for the GLP-1 panel required within 90 days of starting and then annually, $133 for the men's TRT initial panel and $103 for the maintenance panel required at 90 days and annually, $70 and $128 for the women's equivalents, and $293–$301 for the comprehensive panels. Its own cost guide notes that some platforms include labs and others charge $100–$300 per panel — and then shows you which it is, which is the useful part.
How many states does NEUVÉ serve?
The site is inconsistent. Its homepage says "members in 40+ states", while other pages state nationwide and all 50 states. Those are not the same claim, and we have recorded the more conservative one. Given that compounded GLP-1 and testosterone availability both vary by state, confirm your own during the three-minute assessment rather than relying on either figure.
Is NEUVÉ Health legit?
NEUVÉ Health is a GLP-1 telehealth service you reach through an online questionnaire and a video visit with a clinician. The medications it names are Compounded semaglutide and Compounded tirzepatide. Its stated availability: 40+ states. What it publishes up front: Semaglutide $138–$217/mo and tirzepatide $160–$324 by route and dose; labs itemized from $45. It is cash-pay and states it does not bill insurance. Those are the provider's own published claims rather than checks we could run ourselves, so get the ones that matter to you confirmed in writing before you pay.
Is NEUVÉ Health expensive compared with other GLP-1 telehealth providers?
NEUVÉ Health publishes a starting figure of $138/mo. Across the 42 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts NEUVÉ Health below the median, toward the cheaper end. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.